公司资料
RAPT Therapeutics 股价、新闻与催化剂
- 股票代码:
- RAPT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for RAPT.
公司概览
业务概览
RAPT Therapeutics is an immunology company focused on oral small molecules for inflammatory disease and oncology. The company has had to navigate setbacks while rebuilding confidence in its pipeline.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, RAPT sits in specialty biotechnology.
商业模式特征
The model depends on clinical reset, pipeline credibility, and the ability to create a differentiated immunology story.
生物医药行业定位
RAPT is a turnaround-sensitive immunology name whose stock can move sharply when the pipeline revalidates.
未来催化剂
- RAPT Therapeutics's catalysts are its remaining immunology programs and any strategic update that clarifies the next development path after earlier setbacks. The company still needs a cleaner path forward.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。